Statin use in postmenopausal women associated with increased diabetes risk

The use of statins in postmenopausal women is associated with increased diabetes risk, according to a study published Online First by the Archives of Internal Medicine.

But researchers note statins address the cardiovascular consequences of diabetes and current guidelines for primary and secondary prevention should not change. Likewise, researchers write that guidelines for statin use in nondiabetic populations also should not change.

Annie L. Culver, B. Pharm, Rochester Methodist Hospital, Mayo Clinic, Rochester, Minn., and colleagues analyzed data from the national, multiyear Women's Health Initiative in the study.

In this study, researchers used WHI data through 2005 and included 153,840 women without diabetes and with a mean (average) age of 63.2 years. Statin use was assessed at enrollment and in year three. At baseline, 7.04 percent of women reported taking statin medication.

The results indicate 10,242 new cases of diabetes and statin use at baseline was associated with an increased risk of diabetes. This association remained after adjusting for other potential variables, including age, race/ethnicity and , and was observed for all types of statins.

"The results of this study imply that statin use conveys an increased risk of new-onset DM in postmenopausal woman. In keeping with the findings of other studies, our results suggest that statin-induced DM is a medication class effect and not related to potency or to individual statin," the researchers write.

"However, the consequences of statin-induced DM (diabetes mellitus) have not been specifically defined and deserve more attention. Given the wide use of statins in the , further studies among women, men, and diverse ethnicities will clarify DM risk and risk management to optimize therapy," researchers conclude.

More information: Arch Intern Med. Published Online January 9, 2012. doi:10.1001/archinternmed.2011.1246

add to favorites email to friend print save as pdf

Related Stories

Study finds no link between statins and cancer risk

Jul 25, 2011

(Medical Xpress) -- A new study published in the Journal of the American College of Cardiology reports that, contrary to previous studies, the use of cholesterol reducing statin drugs does not increase the risk of patien ...

Statins did not reduce colorectal cancer in WHI analysis

Nov 08, 2010

The use of statins among a group of postmenopausal women did not reduce the risk for colorectal cancer, according to the results of a prospective analysis of data from the large population-based Women's Health Initiative ...

Recommended for you

Ebola drugs: A factfile

30 minutes ago

There is no licensed treatment or vaccine for Ebola, which has killed more than 3,300 people in West Africa since the start of 2014.

MRSA biofilms in joint fluid make infections tough to tackle

51 minutes ago

Physicians have long speculated at the hard-to-treat nature of joint infection. In an article published in Journal of Infectious Diseases, Thomas Jefferson University scientists, in collaboration with scientists at the Na ...

Officials ask about 80 to watch for Ebola symptoms

2 hours ago

Health officials in Texas have reached out to about 80 people who may have had direct or indirect contact with the man infected with Ebola or someone close to him, a Dallas County Health and Human Services ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

deatopmg
not rated yet Jan 09, 2012
HAs any statin study in women of any age group ever shown any positive effect (for the women that is)?